Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial introductions91
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?89
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review69
Genetic determinants of plasma lipids in Greenlanders55
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease44
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism39
Genetic variation in apolipoprotein A-V in hypertriglyceridemia36
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?31
Alveolar macrophages: guardians of the alveolar lipid galaxy27
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases21
Implementation science and genetic testing for familial hypercholesterolemia21
Oxidized LDL receptors: a recent update20
Lipid metabolism during pregnancy: consequences for mother and child20
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances20
Familial hypercholesterolemia in children and the importance of early treatment20
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1920
Exosomes and lipid metabolism in metabolic and cardiovascular disorders19
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?19
Editorial introductions19
Nutrition and its impact on cardiovascular disease17
Nonalcoholic fatty liver disease: an update17
Recent advances in understanding the spectrum of genetic determinants of lipoprotein(a) levels16
A new SPRING in lipid metabolism15
Familial hypercholesterolemia in pregnancy15
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
Editorial introductions14
The current state of apolipoprotein E in dyslipidemia14
From clinical development to real-world outcomes with inclisiran14
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?13
The need for national and international registries of patients with elevated lipoprotein(a)13
Genetic insights from Greenland: when geography, history and genomics converge13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets13
Evolving guidelines on lipoprotein(a)12
APOE and familial hypercholesterolemia12
Can small dense LDL cholesterol be estimated from the lipid profile?12
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion12
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?12
Editorial introductions11
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent11
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis11
Cardiomyocytes, sphingolipids and cardio myotoxicity10
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
Newborn screening for lipid disorders10
In the wake of the Scandinavian Simvastatin Survival Study trial10
Distinct roles of size-defined HDL subpopulations in cardiovascular disease9
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review9
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease9
Pregnancy, cardiovascular health, and microchimerism9
0.046858072280884